Hypha Labs, Inc.
Hypha Labs, Inc., engages in the research, development, and commercialization of a bioreactor in the United States. It offers Hypha Micropearl bioreactor, a home appliance designed to accelerate the production of beneficial mushrooms for human consumption. Hypha Labs, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.
Market Cap & Net Worth: Hypha Labs, Inc. (FUNI)
Hypha Labs, Inc. (PINK:FUNI) has a market capitalization of $4.71 Million ($4.71 Million) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #32292 globally and #10601 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hypha Labs, Inc.'s stock price $0.03 by its total outstanding shares 162521825 (162.52 Million).
Hypha Labs, Inc. Market Cap History: 2015 to 2025
Hypha Labs, Inc.'s market capitalization history from 2015 to 2025. Data shows change from $22.75 Million to $4.71 Million (-18.46% CAGR).
Hypha Labs, Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hypha Labs, Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.44x
Hypha Labs, Inc.'s market cap is 0.44 times its annual revenue
0.69x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $31.69 Million | $818.58K | -$3.70 Million | 38.72x | N/A |
| 2017 | $61.11 Million | $1.90 Million | -$1.06 Million | 32.20x | N/A |
| 2018 | $17.88 Million | $2.84 Million | -$1.65 Million | 6.29x | N/A |
| 2019 | $14.30 Million | $2.55 Million | -$1.80 Million | 5.60x | N/A |
| 2020 | $3.66 Million | $2.57 Million | -$2.31 Million | 1.42x | N/A |
| 2021 | $4.62 Million | $2.50 Million | -$687.00K | 1.84x | N/A |
| 2022 | $1.19 Million | $2.70 Million | -$2.06 Million | 0.44x | N/A |
Competitor Companies of FUNI by Market Capitalization
Companies near Hypha Labs, Inc. in the global market cap rankings as of March 18, 2026.
Key companies related to Hypha Labs, Inc. by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Hypha Labs, Inc. Historical Marketcap From 2015 to 2025
Between 2015 and today, Hypha Labs, Inc.'s market cap moved from $22.75 Million to $ 4.71 Million, with a yearly change of -18.46%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $4.71 Million | -3.33% |
| 2024 | $4.88 Million | -25.00% |
| 2023 | $6.50 Million | +447.95% |
| 2022 | $1.19 Million | -74.30% |
| 2021 | $4.62 Million | +26.22% |
| 2020 | $3.66 Million | -74.43% |
| 2019 | $14.30 Million | -20.00% |
| 2018 | $17.88 Million | -70.74% |
| 2017 | $61.11 Million | +92.82% |
| 2016 | $31.69 Million | +39.29% |
| 2015 | $22.75 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Hypha Labs, Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $4.71 Million USD |
| MoneyControl | $4.71 Million USD |
| MarketWatch | $4.71 Million USD |
| marketcap.company | $4.71 Million USD |
| Reuters | $4.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.